Skip to main content

Table 1 Clinical features of the study subjects

From: Characterization of monocyte/macrophage subsets in the skin and peripheral blood derived from patients with systemic sclerosis

Characteristics

 

SSc (n = 51)

Controls (n = 22)

  

lcSSc(n = 33)

dcSSc (n = 18)

 
  

47/4

 

Sex (female/male)

 

32/1

15/3

18/4

  

57.3 (14.1)

 

Age (years), mean (SD)

 

59.3 (14.1)

55.1 (12)

44.1 (42.0)

Duration of disease

 

72.5 (1-240)

 

month, range (min-max)

 

74.5 (6-240)

54.5 (1-144)

 

Organ involvement (No)

Esophagus

15

3

 
 

Heart

2

1

 
 

Kidney

0

0

 
 

Pulmonary hypertension

0

0

 
 

Pulmonary fibrosis

0

0

 
 

Sjögren syndrome

5

9

 

ANA Specificity (No)

Anti-topo I

11

13

 
 

Anti-ACA

10

14

 
 

Anti-U1 RNP

3

3

 

Mean skin score (SD)

 

2.8 (3.4)

11.9 (9.4)

 

Steroid treatment

 

4

5

 
  1. ANA, antinuclear antibodies; Anti-topo I, anti-topoisomerase I antibody; Anti-ACA, anti-centromere antibody; Anti-U1 RNP, anti-uridine 1 ribonucleoprotein antibody; dcSSc, diffuse cutaneous systemic sclerosis; lcSSC, limited cutaneous systemic sclerosis; SD, standard deviation; SSC, systemic sclerosis.
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us